European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Forecast · Health, medical equipment and medicines

Upcoming cardiovascular drug tenders in Spain

In the next 6 months we expect 10 cardiovascular drug tenders in Spain from 10 buyers, 5 of them with high confidence. Most are expected in February 2027 (3). The forecast is computed daily from public data: buyers that tender the same purchase every year, contracts that are ending and grants for works and equipment.

This is a forecast, not an announcement. We estimate these tenders from public data: the buyers' earlier tenders, the end dates of their contracts and the grants they received. A buyer may publish later, differently or not at all — the buyer's own notices are what counts. Methodology.

Expected tenders
10
Buyers
10
High confidence
5

Expected tenders

ExpectedBuyerWhatWhy we expect itConfidence
Jan – Jun 2027
contract ends
OSAKIDETZA - Servicio Vasco de Salud -Director GeneralCardiovascular and anticoagulant drugs
Suministro de Quetiapina (DOE), Heparina sódica (DOE), Inmunoglobulina antiD (RH) (DOE), Fentanilo (DOE) inyectable, Cafeína citrato (DOE), Nicotina (DOE) Parche transdérmico y Pazopanib (DOE)
Typical value: ≈ €2,100
The current contract with Ammon-Ra Librería, S.L. ends on 7 July 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 06/2026
high
Feb – Jul 2027
contract ends
Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión SanitariaCardiovascular and anticoagulant drugs
Suministro respetuoso con el medio ambiente de medicamentos biológicos con biosimilares para el lote 16 Ustekinumba
Typical value: ≈ €2.5m
The current contract with Sandoz Farmaceutica ends on 31 July 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 08/2026
high
Feb – Jul 2027
contract ends
Gerencia de Asistencia Sanitaria de ZamoraCardiovascular and anticoagulant drugs
129/2025/15979"Suministro respetuoso con el medio ambiente de medicamentos de factor VIII de coagulación recombinante, para el Servicio de Farmacia del Hospital Virgen de la Concha perteneciente a la GAS de Zamora. Basado en el Acuerdo Marco 2024/128 del Instituto Nacional de Gestión Sanitaria"
Typical value: ≈ €92,000
The current contract with SWEDISH ORPHAN BIOVITRUM, S.L. ends on 8 August 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 08/2025
medium
Feb – Jul 2027
contract ends
Gerencia de Atención Especializada Hospital Univ. Rio Hortega de ValladolidCardiovascular and anticoagulant drugs
Suministro de medicamentos de Factor VIII de coagulación recombinante – Hospital Universitario Río Hortega
Typical value: ≈ €550,000
The current contract with SWEDISH ORPHAN BIOVITRUM, S.L. ends on 10 August 2027; no new tender has been published yet.
Earlier tenders: 08/2025
high
Mar – Aug 2027
contract ends
Gerencia de Asistencia Sanitaria de SoriaCardiovascular and anticoagulant drugs
Suministro respetuoso con el medio ambiente de medicamentos de Factor VIII de coagulación recombinante para la Gerencia de Asistencia Sanitaria de Soria (Derivado A.M. INGESA 2024/128)
Typical value: ≈ €130,000
The current contract with Novo Nordisk Pharma, S.A. ends on 1 September 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 09/2026
high
Mar – Aug 2027
contract ends
Gerencia de Atención Especializada de BurgosCardiovascular and anticoagulant drugs
suministro respetuoso con el medio ambiente de medicamentos de Factor VIII de coagulación recombinante (lotes: 6 , 8 y 12) para el Complejo Asistencial Universitario de Burgos
Typical value: ≈ €1.1m
The current contract with SWEDISH ORPHAN BIOVITRUM, S.L. ends on 11 September 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 09/2025
medium
Apr – Sep 2027
contract ends
Servicio Madrileño de Salud - Hospital Universitario 12 de OctubreCardiovascular and anticoagulant drugs
2023-0-48 SUMINISTRO DE HEPARINA SÓDICA, CISATRACURIO BESILATO, UROQUINASA Y LEVETIRACETAM CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL UNIVERSITARIO 12 DE OCTUBRE
Typical value: ≈ €11,000
The current contract with LABORATORIOS NORMON, S.A. ends on 13 October 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 06/2024
medium
Apr – Sep 2027
contract ends
Hospital Universitario Clínico San CarlosCardiovascular and anticoagulant drugs
Suministro IOMEPROL (IOMERON) Y HEPARINA SODICA 20 UI/ML (FIBRILIN) de distribución exclusiva, con destino al servicio de Farmacia Hospital Clínico San Carlos
Typical value: ≈ €26,000
The current contract with LABORATORIOS FARMACEUTICOS ROVI, S.A. ends on 20 October 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 10/2026
medium
May – Sep 2027
contract ends
Gerencia de Atención Especializada de SalamancaCardiovascular and anticoagulant drugs
Suministro, respetuoso con el medio ambiente, de medicamentos de Factor VIII de coagulación recombinante (LOTE 6 ELOCTA, LOTE 11ESPEROCT y LOTE 12 ALTUVOCT) con destino al Complejo Asistencial Universitario de Salamanca.
Typical value: ≈ €160,000
The current contract with NOVO NORDISK PHARMA SA ends on 28 October 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 10/2025
medium
May – Oct 2027
contract ends
Dirección del Instituto Nacional de Gestión Sanitaria (INGESA)Cardiovascular and anticoagulant drugs
Suministro, respetuoso con el medio ambiente, de medicamentos epoetinas, para varias comunidades autónomas, centros del Instituto Nacional de Gestión Sanitaria (INGESA) en Ceuta y Melilla y organismos de la Administración del Estado
Typical value: ≈ €52m
The current contract with AMGEN, S.A. ends on 4 November 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 11/2025
high

Expected by month

  • January 2027 1
  • February 2027 3
  • March 2027 2
  • April 2027 2
  • May 2027 2

In other countries

Published tenders

Questions and answers

Which cardiovascular drug tenders are planned in Spain?
We expect 10 tenders from 10 buyers in the coming months. The next ones: OSAKIDETZA - Servicio Vasco de Salud -Director General — Cardiovascular and anticoagulant drugs (Jan – Jun 2027); Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria — Cardiovascular and anticoagulant drugs (Feb – Jul 2027); Gerencia de Asistencia Sanitaria de Zamora — Cardiovascular and anticoagulant drugs (Feb – Jul 2027).
When are cardiovascular drug tenders published in Spain?
By the forecast, most in February 2027: 3.
How do you know a tender will be published?
We do not know for sure — it is a forecast from public data: the buyer published the same kind of tender in at least two consecutive years around the same date, its service or supply contract is ending, or it received a grant for works or equipment and has not tendered yet. Methodology
What does the confidence mean?
High: three years in a row within three weeks of the same date, or several signals at once. Medium: two years in a row or a wider window, an ending contract or a large grant. We do not show forecasts of low confidence.
Is this an official procurement plan?
No. Many buyers publish their own procurement plans and prior information notices — binding dates are only there and in the contract notices themselves.